Biocon Market Cap

Biocon has a market cap or net worth of 391.06 billion as of April 24, 2025. Its market cap has increased by 21.28% in one year.

Market Cap

391.06B

Enterprise Value

589.53B

Revenue

147.62B

Ranking

n/a

PE Ratio

48.69

Stock Price

325.75

Market Cap Chart

Since April 7, 2004, Biocon's market cap has increased from 45.41B to 391.06B, an increase of 761.11%. That is a compound annual growth rate of 10.77%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2025	401.77B	-8.12%
Dec 31, 2024	437.25B	46.69%
Dec 29, 2023	298.08B	-4.59%
Dec 30, 2022	312.41B	-27.97%
Dec 31, 2021	433.73B	-21.37%
Dec 31, 2020	551.59B	58.78%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	4,192.60B
Divi's Laboratories	1,572.77B
Cipla	1,234.20B
Mankind Pharma	1,064.25B
Apollo Hospitals Enterprise	1,019.22B
Zydus Lifesciences	873.41B
Aurobindo Pharma	724.14B
Alkem Laboratories	625.68B

Market Cap Rankings